Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Ameriprise Financial EVP Melloh Exercises Stock Options

Heather J. Melloh, EVP and General Counsel of Ameriprise Financial Inc, filed a Form 4 on August 12, 2026, disclosing transactions in Ameriprise Financial common stock dated August 10, 2026.

Vinay Lochav | 12 August 2026

Applied Optoelectronics CFO Sells 4,000 Shares in August 2026

Stefan J. Murry, Chief Financial Officer of Applied Optoelectronics, Inc. (NASDAQ:AAOI), filed a Form 4 on August 12, 2026, disclosing the sale of 4,000 shares of common stock on August 10, 2026.

Shwetambri Chauhan | 12 August 2026

Criteo CFO Receives 23,090 Ordinary Shares in August 2026

Connor McGogney, Chief Financial Officer of Criteo S.A. (NASDAQ:CRTO), filed a Form 4 on August 12, 2026, disclosing the acquisition of 23,090 ordinary shares on August 10, 2026, at a price of $0 per share.

Anjali Anand | 12 August 2026

Centuri Holdings EVP Receives RSU Grant in August 2026

Danielle E. Hunter, Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary of Centuri Holdings, Inc. (NYSE:CTRI), filed a Form 4 on August 12, 2026, disclosing the acquisition of restricted stock units under the company's Omnibus Incentive Plan.

Shwetambri Chauhan | 12 August 2026

Centuri Holdings CFO Receives 72,864 RSU Grant

A Form 4 filed on August 12, 2026 reported that Kelly Youngblood, Executive Vice President and Chief Financial Officer of Centuri Holdings, Inc. (NYSE:CTRI), received a grant of 72,864 restricted stock units under the company's Omnibus Incentive Plan.

Anjali Anand | 12 August 2026

Pershing Square Inc. Reports Q2 2026 Financial Results

Pershing Square Inc. filed a current report on August 12, 2026, disclosing its financial results for the second quarter ended June 30, 2026, along with a letter to shareholders from company leadership.

Aakashdeep | 12 August 2026

American Express Issues Series E Preferred Shares, Plans Series D Redemption

American Express Company filed a Form 8-K with the SEC on August 12, 2026, disclosing the issuance of 1,600,000 Depositary Shares representing a new series of preferred stock and announcing a planned full redemption of its existing Series D preferred securities.

Shwetambri Chauhan | 12 August 2026

Commercial Bancgroup Files 10-Q for Q2 2026

Commercial Bancgroup, Inc. (NASDAQ:CBK), a Tennessee-based bank holding company, filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 12, 2026, covering the period ended June 30, 2026.

Shwetambri Chauhan | 12 August 2026

Silence Therapeutics Prices Public ADS Offering at $13.50

Silence Therapeutics plc filed a current report on Form 8-K on August 12, 2026, disclosing that it entered into an underwriting agreement on August 11, 2026, to sell American Depositary Shares in an underwritten public offering priced at $13.50 per ADS.

Nitish Kishor | 12 August 2026

Cerebras Systems Files Q2 2026 Quarterly Report

Cerebras Systems Inc. submitted its Form 10-Q for the quarterly period ended June 30, 2026, filed with the U.S. Securities and Exchange Commission and disclosing share counts, company structure, and operational context for the AI compute company.

Aditi Sarkar | 12 August 2026
Support

Hi! How can we help you today?

Loading…